Lamisil Uno

"Lamisil Uno" bụ antifungal n'ụlọnga. Agwọ ọrịa zubere maka mpụga na ngwa ma nwere a zuru ezu dịgasị iche iche nke mmetụta. Obere kasịnụ nke ọgwụ nwere a fungicidal mmetụta dermatophytes, Ebu na ụdị ụfọdụ nke dimorphic dịkwa ka usoro ha. "Lamisil Uno" na-akwanyere ndị yist dịkwa ka usoro ha nwere ike (dabere na umu) fungistatic ma ọ bụ fungicidal mmetụta.

Mgbe etinyere topically kwuru obere (ihe na-erughị 5%) absorbability onunu ogwu nke na-akpata nnọọ ala absorption n'ime systemic mgbasa.

Ọgwụ "Lamisil Uno" gosiri maka ọgwụgwọ na mgbochi nke fungal akpụkpọ-efe efe. Ndị a gụnyere tinea pedis, jock oko, metụ akwa ọkụ ọkụ, pityriasis versicolor. Na-egosi na-yist na-efe efe iwe na fungi nke genus Candida, ezigbo anụ ọnya mere site ụfọdụ dermatophytes.

Ọgwụ "Lamisil Uno": okwu

Maka ọrịa tọrọ afọ iri na abụọ na-atụ aro iji otu - ugboro abụọ n'ụbọchị, dị ka ihe àmà ahụ. Tupu itinye ego "Lamisil" ijide n'aka na-ọcha na nkụ otụk ebe. The ude na-etinyere a mkpa oyi akwa bụghị naanị na nsogbu ebe, kamakwa n'akụkụ ebe. Emepụta nta rubbing.

Ọ bụrụ na metụ akwa ọkụ ọkụ so site na-efe efe (interdigital oghere, na ukwu ebe, n'etiti ike, n'okpuru ara) na-ekwe na-ekpuchi ebe ahụ na fere fere lubrication, karịsịa n'abalị.

The nkezi oge na ugboro ole ọnụego nke ọgwụ na ọgwụgwọ nke tinea n'akụkụ ikpere, toso, ụkwụ - izu nke otu ugboro n'ụbọchị; na Actinic, ekpepụsị, itching na cracks iwe na a ero ụkwụ, nakwa dị ka multi-acha lichen - ugboro ma ọ bụ ugboro abụọ n'ụbọchị, maka izu abụọ.

A, belata ogo ngosipụta hụrụ n'oge ụbọchị mbụ nke ọgwụ. Oge ufodu iji ọgwụ ma ọ bụ na-anwụchu discontinuation ọgwụgwọ nwere ike otu nọọrọ onwe ha na-akpata ọhụrụ ọrịa. Ọ bụrụ na mma adịghị ime ọbụna mgbe a izu, ọ dị mkpa ezipụta na nchoputa.

"Lamisil" Erere ndu tụrụ aro na-ewere otu ugboro n'ụbọchị. A otu dose a gbakọọ dabere na ibu ibu. Maka ụmụaka, na-enwe a uka nke na-erughị 20 n'arọ - 62,5 mg, ukwuu karịa 20 ma na-erughị 40 - 125 mg ọzọ 40 - 250 mg. Dị ka omume na-egosi, ndị ọrịa na ndị agadi karịrị afọ abụọ na-ọma anabata ingestion nke mbadamba.

N'ihi na ndị okenye na-atụ aro dose - 250 mg otu ugboro n'ụbọchị.

"Lamisil Uno" (ude) ghara ga-eji na ụmụ obere karịa 12 afọ.

Iji ọgwụ ike na mpaghara ime ka ọkụ, itching, nācha ọbara-ọbara na ndị ọzọ na-adịghị anabata Jeremaya mere.

Contraindicated ude "Lamisil" bụrụ na nke hypersensitivity.

Ịkpachara anya ga-gosipụtara ná nhọpụta nke ọgwụ na ọrịa na hepatic, gbasara akụrụ insufficiency, etuto ahụ, ala ala aṅụrụma, vaskụla ọrịa aka na ụkwụ occlusive agwa, mgbochi nke ụmị ọkpụkpụ hematopoiesis.

Iji nke ọgwụ na ụmụaka kwesịrị n'okpuru dọkịta na-elekọta.

ezughi oke data banyere ojiji nke ude "Lamisil" na ụmụ nwaanyị dị ime. The oru nke ọgwụ n'oge gestation naanị ọkachamara na-atụ aro.

The n'ọrụ mgwa (terbinafine) ọ na-anyụpụ na mmiri ara nke lactating inyom. Mgbe eji n'oge lactation bụ eleghi anya na-ezighị ezi mmetụta na nwa, na anya nke na-negligible systemic absorption nke ọgwụ site akpụkpọ. Otú ọ dị, nhọpụta a mere a ọkachamara.

Inweta mpụga nkwadebe iyatesịt emee na anya. N'ọnọdụ dị otú ahụ ga-rinsed ozugbo na mmiri. Na mmepe nke adigide iyatesịt kwesịrị ịga leta a dọkịta.

Ikpe nke ovadozu ude "Lamisil" na-adịghị kọwara. Mberede onu ochichi nwere ike ime ka ọgbụgbọ, isi ọwụwa, epigastric mgbu. Etinyere ọrụ carbon, symptomatic ọgwụgwọ a rụrụ ma ọ bụrụ na ọ dị mkpa.